HIGHLIGHTS
- who: Salomu00e9 Desmecht from the Ghent University, University of Oxford, United Kingdom have published the Article: Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections, in the Journal: (JOURNAL)
- how: For the time points comparison the authors used unpaired testing.
- future: Studies are needed to better determine the usefulness of anti-spike antibodies for COVID-19 treatment prioritization.
SUMMARY
Indeed, 8 months after COVID-19 mRNA_vaccination, the median live . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.